Stroke rehabilitation

DeLisa's Physical Medicine and Rehabilitation: Principles and Practice: Fifth Edition

Volumn 1-2, Issue , 2012, Pages 551-574

  Stein, Joel ^a,b,c   Brandstater, Murray E ^d  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973412739     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (145)

1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation.. 2008;117:e25-e146.
2. Kannel WB, Dawber TR, Sorlie P, et al. Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham study. Stroke.. 1976;7:327-331.
3. Group PC. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack [see comment] [erratum appears in Lancet 2001;358(9292):1556]. Lancet.. 2001;358:1033-1041.
4. Yusuf S, Diener HC, Sacco RL, et al. Telmisartan to prevent recurrent stroke and cardiovascular events [see comment]. N Engl J Med.. 2008; 359:1225-1237.
5. Oliveira-Filho J, Silva SC, Trabuco CC, et al. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset [see comment]. Neurology.. 2003;61:1047-1051.
6. Wolf PA, Kannel WB, Venter J. Current status of risk factors for stroke. Neurol Clin.. 1983;1:317-343.
7. Wolf PA, Dawber TR, Thomas HE Jr, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology.. 1978;28:973-977.
8. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest.. 2008;133:546S-592S.
9. Abraira C, Colwell J, Nuttall F, et al. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med.. 1997;157:181-188.
10. Meigs JB, Singer DE, Sullivan LM, et al. Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): the NIDDM Patient Outcome Research Team [see comment]. Am J Med.. 1997;102:38-47.
11. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women [see comment]. JAMA.. 1993;269:232-236.
12. Amarenco P, Bogousslavsky J, Callahan A et al. High-dose atorvastatin after stroke or transient ischemic attack [see comment]. N Engl J Med.. 2006;355:549-559.
13. Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke.. 2008;39:1647-1652.
14. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial [see comment]. JAMA.. 2004;291:565-575.
15. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline [see comment]. Stroke.. 2006;37:577-617.
16. Ridker PM, Danielson E, Fonseca FAH. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med.. 2008;359:2195-2207.
17. Sacco RL. Risk factors and outcomes for ischemic stroke. Neurology.. 1995;45:S10-S14.
18. Viitanen M, Eriksson S, Asplund K. Risk of recurrent stroke, myocardial infarction and epilepsy during long-term follow-up after stroke. Eur Neurol.. 1988;28:227-231.
19. Leonberg SC, Jr, Elliott FA. Prevention of recurrent stroke. Stroke.. 1981;12:731-735.
20. Mohr JP, Caplan LR, Melski JW, et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology.. 1978;28:754-762.
21. Redgrave JN, Coutts SB, Schulz UG, et al. Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke.. 2007;38:1482-1488.
22. Purroy F, Montaner J, Rovira A, et al. Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions [see comment]. Stroke.. 2004;35:2313-2319.
23. Dyken ML, Conneally M, Haerer AF, et al. Cooperative study of hospital frequency and character of transient ischemic attacks. I. Background, organization, and clinical survey. JAMA.. 1977;237:882-886.
24. Feinberg WM, Albers GW, Barnett HIM. Guidelines for the management of transient ischemic attacks. Stroke.. 1994;25:1320-1335.
25. Paciaroni M, Agnelli G, Micheli S, et al. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials [see comment]. Stroke.. 2007;38:423-430.
26. Kelly PJ, Furie KL, Shafqat S, et al. Functional recovery following rehabilitation after hemorrhagic and ischemic stroke. Arch Phys Med Rehabil.. 2003;84:968-972.
27. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage [see comment]. N Engl J Med.. 2008;358:2127-2137.
28. Fang MC, Chang Y, Hylek EM, et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation [see comment] [summary for patients in Ann Intern Med.. 2004;141(10):I38; PMID: 15545670]. Ann Intern Med.. 2004;141:745-752.
29. Kelly PJ, Stein J, Shafqat S, et al. Functional recovery after rehabilitation for cerebellar stroke. Stroke.. 2001;32:530-534.
30. Bederson JB, Awad IA, Wiebers DO, et al. Recommendations for the management of patients with unruptured intracranial aneurysms: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation.. 2000;102:2300-2308.
31. Anonymous. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group [see comment]. N Engl J Med.. 1995;333:1581-1587.
32. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke [see comment]. N Engl J Med.. 2008;359:1317-1329.
33. Hacke W, Albers G, Al-Rawi Y, et al. The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke.. 2005;36:66-73.
34. Tsivgoulis G, Alexandrov A, Tsivgoulis G, et al. Ultrasound-enhanced thrombolysis: from bedside to bench [comment]. Stroke.. 2008;39:1404-1405.
35. Shaltoni HM, Albright KC, Gonzales NR, et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke.. 2007;38:80-84.
36. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial [see comment]. Stroke.. 2005;36:1432-1438.
37. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial [see comment]. Lancet.. 2004;364:331-337.
38. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke [see comment]. J Neurol Sci.. 1996;143:1-13.
39. Sacco RL, Diener HC, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke [see comment]. N Engl J Med.. 2008;359:1238-1251.
40. Kent DM, Thaler DE, Kent DM, et al. Stroke prevention-insights from incoherence [comment]. N Engl J Med.. 2008;359:1287-1289.
41. Barnett HJ, Taylor DW, Eliasziw M, et al. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. [see comment]. N Engl J Med.. 1998;339:1415-1425.
42. Chaturvedi S, Bruno A, Feasby T, et al. Carotid endarterectomy-an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology.. 2005;65:794-801.
43. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis [see comment]. N Engl J Med.. 2006;355:1660-1671.
44. Collaboration SUT. Colllaboration SUT: collaborative systematic review of the randomised trials of organized inpatient (stroke unit) care after stroke. Br Med J.. 1997;314:1151-1159.
45. Langhorne P, Pollock A, Stroke Unit Trialists C, et al. What are the components of effective stroke unit care? Age Ageing.. 2002;31:365-371.
46. Roth EJ. Medical complications encountered in stroke rehabilitation. Phys Med Rehabil Clin N Am.. 1991;2:563-578.
47. DePippo KL, Holas MA, Reding MJ. The Burke dysphagia screening test: validation of its use in patients with stroke [see comment]. Arch Phys Med Rehabil.. 1994;75:1284-1286.
48. Horner J, Massey EW, Riski JE, et al. Aspiration following stroke: clinical correlates and outcome. Neurology.. 1988;38:1359-1362.
49. Gresham GE, Duncan PW, Stason WB, et al. Post-stroke rehabilitation: Clinical Practice Guideline No. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 95-0662; 1995.
50. Foulkes MA, Wolf PA, Price TR, et al. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke.. 1988;19:547-554.
51. Twitchell TE. The restoration of motor function following hemiplegia in man. Brain.. 1951;74:443-480.
52. Nakayama H, Jorgensen HS, Raaschou HO, et al. Recovery of upper extremity function in stroke patients: the Copenhagen stroke study. Arch Phys Med Rehabil.. 1994;75:394-398.
53. Bard G, Hirschberg GG. recovery of voluntary motion in upper extremity following hemiplegia. Arch Phys Med Rehabil.. 1965;46:567-572.
54. Gowland C. Management of hemiplegia upper limb. In: Brandstater ME, Basmajian JV, eds. Stroke Rehabilitation.. Baltimore: Williams & Wilkins; 1987:217-245.
55. Wade DT, Langton-Hewer R, Wood VA, et al. The hemiplegic arm after stroke: measurement and recovery. J Neurol Neurosurg Psychiatry.. 1983;46:521-524.
56. Jorgensen H, Nakayam H, Raaschou H. Stroke rehabilitation: outcome and speed of recovery. Part II: speed of recovery: the Copenhagen stroke study. Arch Phys Med Rehabil.. 1995;3:65-70.
57. Kelly-Hayes M, Wolf PA, Kase CS. Time course of functional recovery after stroke: the Framingham study. J Neurol Rehabil.. 1989;3:65-70.
58. Wade DT, Hewer RL, David RM, et al. Aphasia after stroke: natural history and associated deficits. J Neurol Neurosurg Psychiatry.. 1986;49:11-16.
59. Skilbeck CE, Wade DT, Hewer RL, et al. Recovery after stroke. J Neurol Neurosurg Psychiatry.. 1983;46:5-8.
60. Krakauer JW. Motor learning: its relevance to stroke recovery and neurorehabilitation. Curr Opin Neurol.. 2006;19:84-90.
61. Liepert J, Bauder H, Wolfgang HR, et al. Treatment-induced cortical reorganization after stroke in humans. Stroke.. 2000;31:1210-1216.
62. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res.. 1975;12:189-198.
63. Rossi PW, Kheyfets S, Reding MJ. Fresnel prisms improve visual perception in stroke patients with homonymous hemianopia or unilateral visual neglect. Neurology.. 1990;40:1597-1599.
64. Seliger G, Hornstein A, Flax J. Fluoxetine improves emotional incontinence. Brain Inj.. 1991;5:1-4.
65. Robinson RG, Parikh RM, Lipsey JR, et al. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study [see comment]. Am J Psychiatry.. 1993;150:286-293.
66. Horrocks JA, Hackett ML, Anderson CS, et al. Pharmaceutical interventions for emotionalism after stroke. Stroke.. 2004;35:2610-2611.
67. Brandstater ME. Basic aspects of impairment evaluation in stroke patients. In: Chino N, Melvin JL, eds. Functional Evaluation of Stroke Patients.. New York: Springer-Verlag; 1996:9-18.
68. Robey RR. A meta-analysis of clinical outcomes in the treatment of aphasia. J Speech Lang Hear Res.. 1998;41:172-187.
69. Greener J, Enderby P, Whurr R. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev.. 2000:CD000425.
70. Bhogal SK, Teasell R, Speechley M, et al. Intensity of aphasia therapy, impact on recovery [see comment]. Stroke.. 2003;34:987-993.
71. Pulvermuller F, Neininger B, Elbert T, et al. Constraint-induced therapy of chronic aphasia after stroke. Stroke.. 2001;32:1621-1626.
72. Martino R, Foley N, Bhogal S, et al. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke.. 2005;36:2756-2763.
73. Teasell RW, Bach D, McRae M. Prevalence and recovery of aspiration poststroke: a retrospective analysis. Dysphagia.. 1994;9:35-39.
74. Horner J, Massey EW, Brazer SR. Aspiration in bilateral stroke patients. Neurology.. 1990;40:1686-1688.
75. Horner J, Massey EW. Silent aspiration following stroke. Neurology.. 1988;38:317-319.
76. Axelsson K, Asplund K, Norberg A, et al. Nutritional status in patients with acute stroke. Acta Med Scand.. 1988;224:217-224.
77. Brain MRCGo. Aids to the Examination of the Peripheral Nervous System.. London: Bailliere Tindall; 1986.
78. Bohannon RW. Is the measurement of muscle strength appropriate in patients with brain lesions? A special communication [see comment]. Phys Ther.. 1989;69:225-236.
79. Brunnstrom S. Movement Therapy in Hemiplegia: A Neurophysiological Approach.. New York: Harper & Row; 1970.
80. Bohannon R. Correlation of lower limb strengths and other variables with standing performance in stroke patients. Physiother Can.. 1989;41:198-202.
81. Fugl-Meyer AR, Jaasko L, Leyman I, et al. The post-stroke hemiplegic patient. A method for evaluation of physical performance. Scand J Rehabil Med.. 1975;7:13-31.
82. Wolf SL, Catlin PA, Ellis M, et al. Assessing Wolf motor function test as outcome measure for research in patients after stroke. Stroke.. 2001;32:1635-1639.
83. Uswatte G, Taub E, Morris D, et al. The Motor Activity Log-28: assessing daily use of the hemiparetic arm after stroke. Neurology.. 2006;67:1189-1194.
84. Hsieh CL, Hsueh IP, Chiang FM, et al. Inter-rater reliability and validity of the action research arm test in stroke patients. Age Ageing.. 1998;27:107-113.
85. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther.. 1987;67:206-207.
86. Bobath B. Adult Hemiplegia: Evaluation and Treatment.. London: Heinemann; 1976.
87. Wolf SL, Winstein CJ, Miller JP, et al. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA.. 2006;296:2095-2104.
88. Fasoli SE, Krebs HI, Stein J, et al. Robotic therapy for chronic motor impairments after stroke: Follow-up results. Arch Phys Med Rehabil.. 2004;85:1106-1111.
89. Wolf SL, Lecraw DE, Barton LA, et al. Forced use of hemiplegic upper extremities to reverse the effect of learned nonuse among chronic stroke and head-injured patients. Exp Neurol.. 1989;104:125-132.
90. Taub E, Miller NE, Novack TA. A technique for improving chronic motor deficit after stroke. Arch Phys Med Rehabil.. 1993;74:347-354.
91. Taub E, Wolf SL. Constraint induced movement techniques to facilitate upper extremity use in stroke patients. Top Stroke Rehabil.. 1997;3:38-61.
92. Schaechter JD, Kraft E, Hilliard TS, et al. Motor recovery and cortical reorganization after constraint-induced movement therapy in stroke patients: a preliminary study. Neurorehabil Neural Repair.. 2002;16:326-338.
93. Luft AR, McCombe-Waller S, Whitall J, et al. Repetitive bilateral arm training and motor cortex activation in chronic stroke: a randomized controlled trial [erratum appears in JAMA.. 2004;292(20):2470]. JAMA.. 2004;292:1853-1861.
94. Page SJ, Levine P, Leonard A, et al. Modified constraint-induced therapy in chronic stroke: results of a single-blinded randomized controlled trial [see comment]. Phys Ther.. 2008;88:333-340.
95. Aisen ML, Krebs HI, Hogan N, et al. The effect of robot-assisted therapy and rehabilitative training on motor recovery following stroke. Arch Neurol.. 1997;54:443-446.
96. Volpe BT, Krebs HI, Hogan N, et al. A novel approach to stroke rehabilitation: robot-aided sensorimotor stimulation. Neurology.. 2000;54:1938-1944.
97. Daly JJ, Roenigk K, Holcomb J, et al. A randomized controlled trial of functional neuromuscular stimulation in chronic stroke subjects. Stroke.. 2006;37:172-178.
98. Schleenbaker RE, Mainous AG Electromyographic biofeedback for neuromuscular reeducation in the hemiplegic stroke patient: a meta-analysis [see comment]. Arch Phys Med Rehabil.. 1993;74:1301-1304.
99. Kraft GH, Fitts SS, Hammond MC. Techniques to improve function of the arm and hand in chronic hemiplegia. Arch Phys Med Rehabil.. 1992;73:220-227.
100. Stein J, Narendran K, McBean J, et al. Electromyography-controlled exoskeletal upper-limb-powered orthosis for exercise training after stroke [erratum appears in Am J Phys Med Rehabil.. 2008;87(8):689]. Am J Phys Med Rehabil. 2007;86:255-261.
101. Hesse S, Bertelt C, Jahnke MT, et al. Treadmill training with partial body weight support compared with physiotherapy in nonambulatory hemiparetic patients [see comment]. Stroke.. 1995;26:976-981.
102. Hesse S, Bertelt C, Schaffrin A, et al. Restoration of gait in nonambulatory hemiparetic patients by treadmill training with partial body-weight support. Arch Phys Med Rehabil.. 1994;75:1087-1093.
103. Pohl M, Mehrholz J, Ritschel C, et al. Speed-dependent treadmill training in ambulatory hemiparetic stroke patients: a randomized controlled trial [see comment]. Stroke.. 2002;33:553-558.
104. Husemann B, Muller F, Krewer C, et al. Effects of locomotion training with assistance of a robot-driven gait orthosis in hemiparetic patients after stroke: a randomized controlled pilot study. Stroke.. 2007;38:349-354.
105. Hornby TG, Campbell DD, Kahn JH, et al. Enhanced gait-related improvements after therapist- versus robotic-assisted locomotor training in subjects with chronic stroke: a randomized controlled study. Stroke.. 2008;39:1786-1792.
106. Frese A, Husstedt IW, Ringelstein EB, et al. Pharmacologic treatment of central post-stroke pain. Clin J Pain.. 2006;22:252-260.
107. Vestergaard K, Andersen G, Gottrup H, et al. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology.. 2001;56:184-190.
108. Ganesan V, Ng V, Chong WK, et al. Lesion volume, lesion location, and outcome after middle cerebral artery territory stroke. Arch Dis Child.. 1999;81:295-300.
109. Wade DT, Wood VA, Hewer RL. Recovery after stroke-the first 3 months. J Neurol Neurosurg Psychiatry.. 1985;48:7-13.
110. Gresham GE, Fitzpatrick TE, Wolf PA, et al. Residual disability in survivors of stroke-the Framingham study. N Engl J Med.. 1975;293:954-956.
111. Granger CV, Hamilton BB, Linacre JM, et al. Performance profiles of the functional independence measure. Arch Phys Med Rehabil.. 1993;72:84-89.
112. Feigenson JS, McDowell FH, Meese P, et al. Factors influencing outcome and length of stay in a stroke rehabilitation unit. Part Analysis of 248 unscreened patients-medical and functional prognostic indicators. Stroke.. 1977;8:651-656.
113. Wade DT, Hewer RL. Functional abilities after stroke: measurement, natural history and prognosis. J Neurol Neurosurg Psychiatry.. 1987;50:177-182.
114. Dombovy ML, Basford JR, Whisnant JP, et al. Disability and use of rehabilitation services following stroke in Rochester, Minnesota, 1975-Stroke.. 1987;18:830-836.
115. Wade DT, Skilbeck CE, Hewer RL. Predicting Barthel ADL score at 6 months after an acute stroke. Arch Phys Med Rehabil.. 1983;64:24-28.
116. Ostwald SK, Swank PR, Khan MM, et al. Predictors of functional independence and stress level of stroke survivors at discharge from inpatient rehabilitation. J Cardiovasc Nurs.. 2008;23:371-377.
117. Horn SD, DeJong G, Smout RJ, et al. Stroke rehabilitation patients, practice, and outcomes: is earlier and more aggressive therapy better?[see comment]. Arch Phys Med Rehabil.. 2005;86:S101-S114.
118. Evans RL, Bishop DS, Matlock AL, et al. Family interaction and treatment adherence after stroke. Arch Phys Med Rehabil.. 1987;68:513-517.
119. Kalra L, Yu G, Wilson K, et al. Medical complications during stroke rehabilitation. Stroke.. 1995;26:990-994.
120. Hertzer NR, Young JR, Beven EG, et al. Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch Intern Med.. 1985;145:849-852.
121. Roth EJ, Mueller K, Green D. Stroke rehabilitation outcome: impact of coronary artery disease. Stroke.. 1988;19:42-47.
122. Roth EJ. Heart disease in patients with stroke. Part II: impact and implications for rehabilitation. Arch Phys Med Rehabil.. 1994;75:94-101.
123. Van Ouwenaller C, Laplace PM, Chantraine A. Painful shoulder in hemiplegia. Arch Phys Med Rehabil.. 1986;67:23-26.
124. Dromerick AW, Edwards DF, Kumar A, et al. Hemiplegic shoulder pain syndrome: frequency and characteristics during inpatient stroke rehabilitation. Arch Phys Med Rehabil.. 2008;89:1589-1593.
125. Chae J, Yu DT, Walker ME, et al. Intramuscular electrical stimulation for hemiplegic shoulder pain: a 12-month follow-up of a multiple-center, randomized clinical trial. Arch Phys Med Rehabil.. 2005;84:832-842.
126. Hecht JS. Subscapular nerve block in the painful hemiplegic shoulder. Arch Phys Med Rehabil.. 1992;73:1036-1039.
127. Davis SW, Petrillo CR, Eichberg RD, et al. Shoulder-hand syndrome in a hemiplegic population: a 5-year retrospective study. Arch Phys Med Rehabil.. 1977;58:353-356.
128. Tepperman PS, Greyson ND, Hilbert L, et al. Reflex sympathetic dystrophy in hemiplegia. Arch Phys Med Rehabil.. 1984;65:442-447.
129. Kamphuisen PW, Agnelli G, Kamphuisen PW, et al. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res.. 2007;119:265-274.
130. Brandstater ME, Roth EJ, Siebens HC. Venous thromboembolism in stroke: literature review and implications for clinical practice. Arch Phys Med Rehabil.. 1992;73:S379-S391.
131. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest.. 2008;133:454S-545S.
132. Robinson RG, Starr LB, Kubos KL, et al. A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke.. 1983;14:736-741.
133. Coll P, Erickson RJ. Mood disorders associated with stroke. Phys Med Rehabil.. 1989;3:619-628.
134. Robinson RG, Szetela B. Mood change following left hemispheric brain injury. Ann Neurol.. 1981;9:447-453.
135. Spalleta G, Caltagirone C. Depression and other neuropsychiatric complications after stroke. In: Stein J, Harvey RL, Macko R, et al., eds. Stroke Recovery and Rehabilitation.. New York: Demos Medical; 2009:2391-2400.
136. Lazarus LW, Moberg PJ, Langsley PR, et al. Methylphenidate and nortriptyline in the treatment of poststroke depression: a retrospective comparison. Arch Phys Med Rehabil.. 1994;75:403-406.
137. Robinson RG, Jorge RE, Moser DJ, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA.. 2008;299:2391-2400.
138. Monga TN. Sexuality post stroke. Phys Med Rehab: State Art Rev.. 1993;7:225-236.
139. Lewis RW, Fugl-Meyer KS, Bosch R, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med.. 2004;1:35-39.
140. Korpelainen JT, Nieminen P, Myllyla VV. Sexual functioning among stroke patients and their spouses [see comment]. Stroke.. 1999;30:715-719.
141. Monga TN, Lawson JS, Inglis J. Sexual dysfunction in stroke patients. Arch Phys Med Rehabil.. 1986;67:19-22.
142. Muller JE, Mittleman MA, Maclure M, et al. Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants of Myocardial Infarction Onset Study Investigators [see comment]. JAMA.. 1996;275:1405-1409.
143. Sinyor D, Amato P, Kaloupek DG, et al. Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome. Stroke.. 1986;17:1102-1107.
144. Kotila M, Numminen H, Waltimo O, et al. Depression after stroke: results of the Finnstroke study. Stroke.. 1998;29:368-372.
145. Devinsky O, Devinsky O. Neurologist-induced sexual dysfunction: enzyme-inducing antiepileptic drugs [comment]. Neurology.. 2005;65:980-981.